BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shah NR, Chen H. MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment. World J Clin Oncol 2014; 5(2): 48-60 [PMID: 24829851 DOI: 10.5306/wjco.v5.i2.48]
URL: https://www.wjgnet.com/2218-4333/full/v5/i2/48.htm
Number Citing Articles
1
Elizabeth Varghese, Alena Liskova, Peter Kubatka, Samson Mathews Samuel, Dietrich Büsselberg. Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer ProgressionBiomolecules 2020; 10(2): 191 doi: 10.3390/biom10020191
2
Yafeng Ma, Laura M. Machesky. Fascin1 in carcinomas: Its regulation and prognostic valueInternational Journal of Cancer 2015; 137(11): 2534 doi: 10.1002/ijc.29260
3
Afshin Taheriazam, Amir Jouya Talaei, Mohammad Jamshidi, Mohammadreza Shakeri, Samaneh Khoshbakht, Emad Yahaghi, Marjan Shokrani. RETRACTED ARTICLE: Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcomaDiagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0422-x
4
Xiaoping Liu, Hailin Tang, Jianping Chen, Cailu Song, Lu Yang, Peng Liu, Neng Wang, Xinhua Xie, Xiaoti Lin, Xiaoming Xie. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancerOncotarget 2015; 6(24): 20070 doi: 10.18632/oncotarget.4039
5
Anqi Ge, Lifang Liu, Xian’guang Deng, Jun Luo, Yanghua Xu, Sri Fatmawati. Exploring the Mechanism of Baicalin Intervention in Breast Cancer Based on MicroRNA Microarrays and Bioinformatics StrategiesEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/7624415
6
Mi-Jia Wang, Hao Zhang, Jun Li, Hai-Dong Zhao. microRNA-98 inhibits the proliferation, invasion, migration and promotes apoptosis of breast cancer cells by binding to HMGA2Bioscience Reports 2018; 38(5) doi: 10.1042/BSR20180571
7
Luming Zheng, Xukui Zhang, Feng Yang, Jian Zhu, Peng Zhou, Fang Yu, Lei Hou, Lei Xiao, Qingqing He, Baocheng Wang. Regulation of the P2X7R by microRNA-216b in human breast cancerBiochemical and Biophysical Research Communications 2014; 452(1): 197 doi: 10.1016/j.bbrc.2014.07.101
8
Fereydoon Abedi-Gaballu, Elham Kamal Kazemi, Seyed Ahmad Salehzadeh, Behnaz Mansoori, Farhad Eslami, Ali Emami, Gholamreza Dehghan, Behzad Baradaran, Behzad Mansoori, William C. Cho. Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAsCells 2022; 11(19): 2973 doi: 10.3390/cells11192973
9
Joanna Magdalena Zarzynska. The Importance of Autophagy Regulation in Breast Cancer Development and TreatmentBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/710345
10
Bruno Costa Gomes, Bruno Santos, José Rueff, António Sebastião Rodrigues. Cancer Drug ResistanceMethods in Molecular Biology 2016; 1395: 189 doi: 10.1007/978-1-4939-3347-1_11
11
Janusz Matuszyk, Dagmara Klopotowska. miR‐125b lowers sensitivity to apoptosis following mitotic arrest: Implications for breast cancer therapyJournal of Cellular Physiology 2020; 235(10): 6335 doi: 10.1002/jcp.29610
12
Anahita Tavakoli, Mohammad Saeed Kahrizi, Kimia Safa, Reza ArefNezhad, Fatemeh Rezaei-Tazangi. Umbilical cord mesenchymal stem cells and breast cancer: a good therapeutic candidate or not? A minireviewMolecular Biology Reports 2022; 49(9): 9017 doi: 10.1007/s11033-022-07739-w
13
Zhe Song, Wei Li, Liang Wang, Nan Jia, Baosheng Chen. MicroRNA-454 inhibits tumor cell proliferation, migration and invasion by downregulating zinc finger E-box-binding homeobox 1 in gastric cancerMolecular Medicine Reports 2017; 16(6): 9067 doi: 10.3892/mmr.2017.7758
14
Nairi Abedi, Samira Mohammadi-Yeganeh, Ameneh Koochaki, Fariba Karami, Mahdi Paryan. miR-141 as potential suppressor of β-catenin in breast cancerTumor Biology 2015; 36(12): 9895 doi: 10.1007/s13277-015-3738-y
15
Zahra Sharifi, Mahmood Talkhabi, Sara Taleahmad. Identification of potential microRNA diagnostic panels and uncovering regulatory mechanisms in breast cancer pathogenesisScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24347-7
16
Sanchi Sukhija, Purvi Purohit, Puneet Pareek, Pawan Kumar Garg, Jeewan Ram Vishnoi, Poonam Abhay Elhence, Shobhan Babu Varthya, Praveen Sharma, Sneha Ambwani, Jaykaran Charan. Circulating miRNA-21 Levels in Breast Cancer Patients Before and After Chemotherapy and Its Association with Clinical ImprovementIndian Journal of Clinical Biochemistry 2023;  doi: 10.1007/s12291-023-01129-0
17
R.L. Akshaya, M. Rohini, Z. He, N.C. Partridge, N. Selvamurugan. MiR-4638-3p regulates transforming growth factor-β1-induced activating transcription factor-3 and cell proliferation, invasion, and apoptosis in human breast cancer cellsInternational Journal of Biological Macromolecules 2022; 222: 1974 doi: 10.1016/j.ijbiomac.2022.09.286
18
Bailong Li, Ying Lu, Honghai Wang, Xiaocui Han, Jun Mao, Jiazhi Li, Lihui Yu, Bo Wang, Shujun Fan, Xiaotang Yu, Bo Song. RETRACTED: miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathwayBiomedicine & Pharmacotherapy 2016; 79: 93 doi: 10.1016/j.biopha.2016.01.045
19
Chiara Avellini, Caterina Licini, Raffaella Lazzarini, Rosaria Gesuita, Emanuela Guerra, Giovanni Tossetta, Clara Castellucci, Stefano Raffaele Giannubilo, Antonio Procopio, Saverio Alberti, Roberta Mazzucchelli, Fabiola Olivieri, Daniela Marzioni. The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancerOncotarget 2017; 8(35): 58642 doi: 10.18632/oncotarget.17407
20
Linzhong Zhang, Hongdong Xuan, Yongchun Zuo, Gaojian Xu, Ping Wang, Youhong Song, Shihua Zhang. Topological characteristics of target genes regulated by abiotic-stress-responsible miRNAs in a rice interactome networkFunctional & Integrative Genomics 2016; 16(3): 243 doi: 10.1007/s10142-016-0481-4
21
Elif Demirdogen Sevinc, Gulsah Cecener, Secil Ak, Berrin Tunca, Unal Egeli, Sehsuvar Gokgoz, Sahsine Tolunay, Ismet Tasdelen. Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancerGene 2016; 590(2): 278 doi: 10.1016/j.gene.2016.05.033
22
Erik R. Nelson, Ching-yi Chang, Donald P. McDonnell. Cholesterol and breast cancer pathophysiologyTrends in Endocrinology & Metabolism 2014; 25(12): 649 doi: 10.1016/j.tem.2014.10.001
23
Muhammad Tariq, Vinitha Richard, Michael J. Kerin. MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor SubtypeBiomedicines 2023; 11(11): 3007 doi: 10.3390/biomedicines11113007
24
Min‐Hsiung Pan, Yi‐Siou Chiou, Li‐Hua Chen, Chi‐Tang Ho. Breast cancer chemoprevention by dietary natural phenolic compounds: Specific epigenetic related molecular targetsMolecular Nutrition & Food Research 2015; 59(1): 21 doi: 10.1002/mnfr.201400515
25
Meriem Boukerroucha, Claire Josse, Sonia ElGuendi, Bouchra Boujemla, Pierre Frères, Raphaël Marée, Stephane Wenric, Karin Segers, Joelle Collignon, Guy Jerusalem, Vincent Bours. Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancersBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1740-9
26
Caterina Licini, Chiara Avellini, Elena Picchiassi, Emanuela Mensà, Sonia Fantone, Deborah Ramini, Chiara Tersigni, Giovanni Tossetta, Clara Castellucci, Federica Tarquini, Giuliana Coata, Irene Giardina, Andrea Ciavattini, Giovanni Scambia, Gian Carlo Di Renzo, Nicoletta Di Simone, Rosaria Gesuita, Stefano R. Giannubilo, Fabiola Olivieri, Daniela Marzioni. Pre-eclampsia predictive ability of maternal miR-125b: a clinical and experimental studyTranslational Research 2021; 228: 13 doi: 10.1016/j.trsl.2020.07.011
27
Samayita Das. Identification and targeting of microRNAs modulating acquired chemotherapy resistance in Triple negative breast cancer (TNBC): A better strategy to combat chemoresistanceMedical Hypotheses 2016; 96: 5 doi: 10.1016/j.mehy.2016.09.004
28
Carmen Griñán‐Lisón, María Auxiliadora Olivares‐Urbano, Gema Jiménez, Elena López‐Ruiz, Coral del Val, Cynthia Morata‐Tarifa, José Manuel Entrena, Amanda Rocío González‐Ramírez, Houria Boulaiz, Mercedes Zurita Herrera, María Isabel Núñez, Juan Antonio Marchal. miRNAs as radio‐response biomarkers for breast cancer stem cellsMolecular Oncology 2020; 14(3): 556 doi: 10.1002/1878-0261.12635
29
Cheng-gui Miao, Wei-jing Shi, You-yi Xiong, Hao Yu, Xiao-lin Zhang, Mei-song Qin, Chuan-lai Du, Tong-wen Song, Bing Zhang, Jun Li. MicroRNA-663 activates the canonical Wnt signaling through the adenomatous polyposis coli suppressionImmunology Letters 2015; 166(1): 45 doi: 10.1016/j.imlet.2015.05.011
30
Hong Yu, Hui Li, Hua Qian, Xia Jiao, Xiaowei Zhu, Xiaoqin Jiang, Guihong Dai, Junxing Huang. Upregulation of miR-301a correlates with poor prognosis in triple-negative breast cancerMedical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0283-2
31
Haifeng Xia, Shaomu Chen, Ke Chen, Haitao Huang, Haitao Ma. MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancerBiomedicine & Pharmacotherapy 2014; 68(8): 951 doi: 10.1016/j.biopha.2014.10.023
32
Michiko Narita, Eri Shimura, Atsumi Nagasawa, Toshiki Aiuchi, Yukari Suda, Yusuke Hamada, Daigo Ikegami, Chizuru Iwasawa, Kazuhiko Arakawa, Katsuhide Igarashi, Naoko Kuzumaki, Yusuke Yoshioka, Takahiro Ochiya, Hideyuki Takeshima, Toshikazu Ushijima, Minoru Narita, Karl X Chai. Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200cPLOS ONE 2017; 12(2): e0172115 doi: 10.1371/journal.pone.0172115
33
Vahid Kia, Maryam Sharif Beigli, Vahedeh Hosseini, Ameneh Koochaki, Mahdi Paryan, Samira Mohammadi-Yeganeh. Is miR-144 an effective inhibitor of PTEN mRNA: a controversy in breast cancerIn Vitro Cellular & Developmental Biology - Animal 2018; 54(9): 621 doi: 10.1007/s11626-018-0282-2
34
Sushmita Bose Nandy, Arunkumar Arumugam, Ramadevi Subramani, Diego Pedroza, Keziah Hernandez, Edward Saltzstein, Rajkumar Lakshmanaswamy. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathwayOncotarget 2015; 6(19): 17366 doi: 10.18632/oncotarget.3953
35
Delu Gan, Shujun Yue, Yulin Jiang, Dian Zhang, He Shi, Husun Qian, Ting Zhou, Wenli Fang, Mengli Yao, Guowei Zuo, Tingmei Chen. Nucleus-located PDK1 regulates growth, invasion and migration of breast cancer cellsLife Sciences 2020; 253: 117722 doi: 10.1016/j.lfs.2020.117722
36
Vijaya Narasihma Reddy Gajulapalli, Vijaya Lakshmi Malisetty, Suresh Kumar Chitta, Bramanandam Manavathi. Oestrogen receptor negativity in breast cancer: a cause or consequence?Bioscience Reports 2016; 36(6) doi: 10.1042/BSR20160228
37
Geraldine Cizeron-Clairac, François Lallemand, Sophie Vacher, Rosette Lidereau, Ivan Bieche, Celine Callens. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1505-5
38
Xin Yu, Zheng Li. The role of MicroRNAs expression in laryngeal cancerOncotarget 2015; 6(27): 23297 doi: 10.18632/oncotarget.4195
39
Xiangsheng Xiao, Xiaojia Huang, Feng Ye, Bo Chen, Cailu Song, Jiahuai Wen, Zhijie Zhang, Guopei Zheng, Hailin Tang, Xiaoming Xie. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancerScientific Reports 2016; 6(1) doi: 10.1038/srep21735
40
Lixia Cheng, Ruixiu Zhou, Min Chen, Linan Feng, Hongyan Li. MicroRNA-150 targets Rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in papillary thyroid carcinomaMolecular Medicine Reports 2017; 16(2): 2217 doi: 10.3892/mmr.2017.6842
41
Yogin Patel, Nirav Shah, Ji Shin Lee, Eleni Markoutsa, Chunfa Jie, Shou Liu, Rachel Botbyl, David Reisman, Peisheng Xu, Hexin Chen. A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growthOncotarget 2016; 7(14): 18295 doi: 10.18632/oncotarget.7577
42
Wei Xia, JueYu Zhou, HaiBo Luo, YunZhou Liu, CanCan Peng, WenLing Zheng, WenLi Ma. MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0383-0
43
Zahra Nouri Ghonbalani, Shiva Shahmohamadnejad, Parvin Pasalar, Ehsan Khalili. Hypermethylated miR-424 in Colorectal Cancer Subsequently Upregulates VEGFJournal of Gastrointestinal Cancer 2022; 53(2): 380 doi: 10.1007/s12029-021-00614-0
44
Apexa Raval, Jigna Joshi, Franky Shah. Significance of metastamiR-10b in breast cancer therapeuticsJournal of the Egyptian National Cancer Institute 2022; 34(1) doi: 10.1186/s43046-022-00120-9
45
Gretel Mendoza-Almanza, Luis Burciaga-Hernández, Vilma Maldonado, Jorge Melendez-Zajgla, Jorge Olmos. Role of platelets and breast cancer stem cells in metastasisWorld Journal of Stem Cells 2020; 12(11): 1237-1254 doi: 10.4252/wjsc.v12.i11.1237
46
Shan Zhang, Wan-Ling Yin, Xin Zhang, Xiao-Yu Zhang. MicroRNA-455 is downregulated in gastric cancer and inhibits cell proliferation, migration and invasion via targeting insulin-like growth factor 1 receptorMolecular Medicine Reports 2017; 16(3): 3664 doi: 10.3892/mmr.2017.6979
47
HUI LI, JIASHUN LUO, BIN XU, KAIJUN LUO, JUAN HOU. MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cellsMolecular Medicine Reports 2015; 12(2): 3121 doi: 10.3892/mmr.2015.3749
48
Fulong Yu, Fei Quan, Jinyuan Xu, Yan Zhang, Yi Xie, Jingyu Zhang, Yujia Lan, Huating Yuan, Hongyi Zhang, Shujun Cheng, Yun Xiao, Xia Li. Breast cancer prognosis signature: linking risk stratification to disease subtypesBriefings in Bioinformatics 2019; 20(6): 2130 doi: 10.1093/bib/bby073
49
Menha Swellam, Amal Ramadan, Enas A. El‐Hussieny, Noha M. Bakr, Naglaa M. Hassan, Mohamed Emam Sobeih, Lobna R. EzzElArab. Clinical significance of blood‐based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markersJournal of Cellular Biochemistry 2019; 120(8): 12321 doi: 10.1002/jcb.28496
50
Mingliang Zhang, Wei Guo, Jun Qian, Benzhong Wang. Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancerOpen Medicine 2016; 11(1): 78 doi: 10.1515/med-2016-0015
51
MIN LI, LULU LIU, WENQIAO ZANG, YUANYUAN WANG, YUWEN DU, XIAONAN CHEN, PING LI, JUAN LI, GUOQIANG ZHAO. miR-365 overexpression promotes cell proliferation and invasion by targeting ADAMTS-1 in breast cancerInternational Journal of Oncology 2015; 47(1): 296 doi: 10.3892/ijo.2015.3015